Endovascular Today

Verified
Magazine
Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurointerventionists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community. Endovascular Today is published 12 times per year and also offers a free biweekly eNewsletter, advising of recent FDA approvals, clinical trial updates, Medicare coverage news, and new product launches. Please visit our subscriptions page for more information on receiving Endovascular Today.

Actions

Share this page

Media Outlet details

Scope Trade/B2B, Consumer
Language English
Country United States of America
Similarweb UVMSimilarweb UVM Request pricing
Comscore UVMComscore UVM Request pricing
Frequency Monthly

Recent Articles

Search

SKYWARD Pivotal Studies of Shockwave SkyRunner Carotid IVL Platform Begin Enrollment

| Endovascular Today Verified
KEY TAKEAWAYS Johnson & Johnson has initiated enrollment in the SKYWARD IDE clinical program evaluating the Shockwave SkyRunner carotid intravascular lithotripsy system before carotid artery stenting. The program consists of two prospective, multicenter, single-arm studies enrolling patients at high surgical risk for carotid endarterectomy through transcarotid and transfemoral approaches.
Open in Who Shared Issue with article?

STRIDE Pivotal Trial of CereVasc’s eShunt System Completes Enrollment

| Endovascular Today Verified
KEY TAKEAWAYS STRIDE pivotal trial is evaluating safety and efficacty of CereVasc’s investigational eShunt system versus ventriculoperitoneal shunting to treat normal pressure hydrocephalus. Patient enrollment across 32 sites in the United States, Canada, and Argentina has been completed with remaining treatment activities scheduled for completion by the end of July 2026. CereVasc expects STRIDE to support a future FDA premarket approval submission. June 24, 2026—CereVasc, Inc.
Open in Who Shared Issue with article?

ESVS Focused Update of PAD Guidelines Addresses Safety Concerns of Paclitaxel

| Endovascular Today Verified
KEY TAKEAWAYS The European Society of Vascular Surgery issues a focused update to its 2024 PAD guidelines in response to new evidence evaluating paclitaxel-coated endovascular devices. The update cites SWEDEPAD trial data showing no meaningful quality-of-life benefit with paclitaxel-coated devices in intermittent claudication and highlighting concerns regarding long-term mortality.
Open in Who Shared Issue with article?

Cook’s Volante Steerable Guiding Sheath Launched in United States

| Endovascular Today Verified
KEY TAKEAWAYS Cook Medical launches the Volante steerable guiding sheath in the United States and select international markets. Volante facilitates intracardiac, renal, and peripheral placement of diagnostic and therapeutic devices. The device is designed to access challenging anatomy while reducing the need for multiple sheath exchanges during endovascular procedures.
Open in Who Shared Issue with article?

Access Vascular and Medline Partner on Commercialization of Cobranded Vascular Access Catheters

| Endovascular Today Verified
KEY TAKEAWAYS Access Vascular and Medline enter into a multiyear agreement to commercialize cobranded HydroMid and HydroPICC vascular access catheters beginning in late 2026. The catheters received an FDA antithrombogenic indication in October 2025 and are designed to address catheter-related thrombosis and occlusion. The products are expected to be offered within customizable procedure kits distributed through Medline’s acute care and Prime Vendor networks. June 23, 2026—Access Vascular, Inc.
Open in Who Shared Issue with article?

Route 92’s Neurovascular Portfolio Approved in Canada

| Endovascular Today Verified
KEY TAKEAWAYS The first commercial procedures were conducted in Canada with Route 92’s HiPoint 88 system and Monopoint approach. Initial procedures were performed after Route 92’s neurovascular portfolio received Health Canada license. Vitor Mendes Pereira, MD, performed the cases at St. Michael’s Hospital in Toronto, Canada. June 22, 2026—Route 92 Medical, Inc. announced that the first commercial cases in Canada were performed with the company’s neurovascular devices.
Open in Who Shared Issue with article?

SYMPHONY-PE Analysis Shows Early Thrombectomy Linked to Better Outcomes

| Endovascular Today Verified
KEY TAKEAWAYS Post hoc analysis of the SYMPHONY-PE trial found greater reductions in mean pulmonary artery pressure among patients who underwent thrombectomy within 12 hours of pulmonary embolism diagnosis. Earlier intervention was associated with a larger reduction in RV/LV ratio. Safety outcomes were similar between early and later treatment groups, with no device-related serious adverse events or deaths reported.
Open in Who Shared View Duplicates (2) Issue with article?

An Interview With Nishita Kothary, MD, FSIR

| Endovascular Today Verified
Research is a core part of your career, often in collaborative settings and leadership roles. How do you approach research as a shared process with other teams and trainees? Being a physician-scientist is probably one of the most exciting aspects of medicine, especially in interventional radiology (IR). We’ve made so much progress in just the last 50 years, and the field keeps growing. Understanding the science, our outcomes, and how we change patients’ lives—this is how we move medicine forward.
Open in Who Shared Issue with article?

Expanding Neurovascular Applications of the Swift™ Coil System

|
By Robert M. Starke, Allison Strickland, Nitin Goyal, With Mohsen Nouri
| Endovascular Today Verified
The Swift™ Coil System (Penumbra, Inc.) is purposefully designed to facilitate efficient vessel occlusion. SwiftSET™ (Penumbra, Inc.) is engineered to optimize vessel wall apposition, thereby facilitating smooth deployment and natural conformity to tight spaces for dense occlusion in small vessels. SwiftPAC™ (Penumbra, Inc.) is engineered like “liquid metal” to function as a soft, space-seeking coil that conforms to the target vessel for dense packing.
Open in Who Shared Issue with article?

Converging Solutions for Sustainable Safety in the Interventional Lab

|
By Stephan Haulon
| Endovascular Today Verified
Radiation exposure and musculoskeletal (MSK) strain remain persistent occupational hazards in endovascular practice, despite decades of operator awareness, routine monitoring, extensive scientific publications, and technical innovations.
Open in Who Shared Issue with article?

Endovascular Today Journalists

Carbone, Tricia
Enright, Kevin
Kelly, Colleen
McChesney, Steven
Pesotski, Matt
Rola, Kat